Neoadjuvant efficacy of breast cancer based on Multi-omics Data
Release date:
2020-12-10
Description:
Breast cancer is the most common cancer diagnosed among women (excluding skin cancers) and is the second leading cause of cancer death among women after lung cancer. Neoadjuvant trials provide endpoints, such as pathological complete response (pCR) to treatment, that potentially translate into meaningful improvements in overall survival and disease-free survival.In response to the clinical needs that the outcome of neoadjuvant chemotherapy for breast cancer are difficult to predict, our project intend to integrate of multi-dimensional information such as radiomics, genomics and clinicopathology data and screen out some imaging omics profile and gene molecular markers that highly correlated with breast cancer Neoadjuvant efficacy and construct an imaging genomics prediction model.
For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.
You need to install the Aspera Connect plugin before uploading your files. If you dont have Aspera Connect plugin installed in your computer, please Download Aspera Connectand install it first.
[path/to/ascp]: Microsoft Windows: C:\Program Files\Aspera\Aspera Connect\bin\ascp.exe or
c:\users\[username]\AppData\Local\Programs\Aspera\Aspera Connect\bin\ascp.exe
Mac OS X: /Applications/Aspera/Connect.app/Contents/Resources/ascp (for admin's installation) or
/Users/[username]/Applications/Aspera/Connect.app/Contents/Resources/ascp (for non-admin's installation)
Linux: /opt/aspera/bin/ascp or
/home/[username]/aspera/connect/bin/ascp
[path/to/key/file] must be an absolute path, e.g.: /home/keys/aspera.openssh
[path/to/folder/containing/files] needs to specify the local folder that contains all the files to upload.
HRA000428.xlsx